Genetic association studies in cancer: Good, bad or no longer ugly?

<p>Abstract</p> <p>For some time, investigators have appreciated that genetic association studies in cancer are complex because of the multi-stage process of cancer and the daunting challenge of analysing genetic variants in population and family studies. Because of recent technolo...

Full description

Bibliographic Details
Main Authors: Savage Sharon A, Chanock Stephen J
Format: Article
Language:English
Published: BMC 2006-06-01
Series:Human Genomics
Subjects:
Online Access:http://www.humgenomics.com/content/2/6/415
id doaj-a9d19ff0a32e49e1843646837b6437d2
record_format Article
spelling doaj-a9d19ff0a32e49e1843646837b6437d22020-11-25T01:03:36ZengBMCHuman Genomics1479-73642006-06-012641542110.1186/1479-7364-2-6-415Genetic association studies in cancer: Good, bad or no longer ugly?Savage Sharon AChanock Stephen J<p>Abstract</p> <p>For some time, investigators have appreciated that genetic association studies in cancer are complex because of the multi-stage process of cancer and the daunting challenge of analysing genetic variants in population and family studies. Because of recent technological advances and annotation of common genetic variation in the human genome, it is now possible for investigators to study genetic variation and cancer risk in many different settings. While these studies hold great promise for unravelling multiple genetic risk factors that contribute to the set of complex diseases called cancer, it is also imperative that study design and methods of interpretation be carefully considered. Replication of results in sufficiently large, well-powered studies is critical if genetic variation is to realise the promise of personalised medicine -- namely, using genetic data to individualise medical decisions. In this regard, the plausibility of validated genetic variants can only be realised by the study of gene-gene and gene-environment interactions. The genetic association study in cancer has come a long way from the days of restriction fragment length polymorphisms, and now promises to scan an entire genome 'agnostically' in search of genetic markers for a disease or outcome. Moreover, the application and interpretation of these studies should be conducted cautiously.</p> http://www.humgenomics.com/content/2/6/415single nucleotide polymorphismhaplotypeassociation studygenome-wide scanlinkage disequilibriumcancer risk
collection DOAJ
language English
format Article
sources DOAJ
author Savage Sharon A
Chanock Stephen J
spellingShingle Savage Sharon A
Chanock Stephen J
Genetic association studies in cancer: Good, bad or no longer ugly?
Human Genomics
single nucleotide polymorphism
haplotype
association study
genome-wide scan
linkage disequilibrium
cancer risk
author_facet Savage Sharon A
Chanock Stephen J
author_sort Savage Sharon A
title Genetic association studies in cancer: Good, bad or no longer ugly?
title_short Genetic association studies in cancer: Good, bad or no longer ugly?
title_full Genetic association studies in cancer: Good, bad or no longer ugly?
title_fullStr Genetic association studies in cancer: Good, bad or no longer ugly?
title_full_unstemmed Genetic association studies in cancer: Good, bad or no longer ugly?
title_sort genetic association studies in cancer: good, bad or no longer ugly?
publisher BMC
series Human Genomics
issn 1479-7364
publishDate 2006-06-01
description <p>Abstract</p> <p>For some time, investigators have appreciated that genetic association studies in cancer are complex because of the multi-stage process of cancer and the daunting challenge of analysing genetic variants in population and family studies. Because of recent technological advances and annotation of common genetic variation in the human genome, it is now possible for investigators to study genetic variation and cancer risk in many different settings. While these studies hold great promise for unravelling multiple genetic risk factors that contribute to the set of complex diseases called cancer, it is also imperative that study design and methods of interpretation be carefully considered. Replication of results in sufficiently large, well-powered studies is critical if genetic variation is to realise the promise of personalised medicine -- namely, using genetic data to individualise medical decisions. In this regard, the plausibility of validated genetic variants can only be realised by the study of gene-gene and gene-environment interactions. The genetic association study in cancer has come a long way from the days of restriction fragment length polymorphisms, and now promises to scan an entire genome 'agnostically' in search of genetic markers for a disease or outcome. Moreover, the application and interpretation of these studies should be conducted cautiously.</p>
topic single nucleotide polymorphism
haplotype
association study
genome-wide scan
linkage disequilibrium
cancer risk
url http://www.humgenomics.com/content/2/6/415
work_keys_str_mv AT savagesharona geneticassociationstudiesincancergoodbadornolongerugly
AT chanockstephenj geneticassociationstudiesincancergoodbadornolongerugly
_version_ 1725200468660977664